Invesco Ltd. Viracta Therapeutics, Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.87 - $5.0 $21,274 - $56,885	-11,377 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.23 - $4.76 $93 - $199	42 Added 0.37%	11,377 $54,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $7.91 $1,348 - $3,164	-400 Reduced 3.41%	11,335 $41,000
Q3 2021 Nov 15, 2021	BUY	$7.84 - $12.53 $92,002 - $147,039	11,735 New	11,735 $94,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.